Connect Biopharma Holdings Ltd - 8-K Filing
Connect Biopharma reports Q3 2026 net loss of $16.2 million and receives Nasdaq delisting notice due to minimum bid price deficiency. (Items: 2.02 Results of Operations and Financial Condition, 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 9.01 Financial Statements and Exhibits)
Tickers: $CNTB
Read the full article at SEC EDGAR
Part of the story Getty Images Holdings, Inc. - 8-K Filing (3 articles)